Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest prostatectomy Stories

2013-06-25 08:29:06

Decipher genomic test independently forecasts risk of metastatic disease better than PSA, Gleason Score, and other commonly used risk assessment tools as determined by clinical outcomes SAN DIEGO, June 25, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced the publication of data demonstrating its Decipher(TM) test outperformed existing risk assessment tools for predicting metastatic prostate cancer in patients following prostate surgery. Decipher more accurately...

2013-06-18 10:28:32

Study suggests low-risk patients can forgo immediate treatment Many men with low-risk, localized prostate cancers can safely choose active surveillance or "watchful waiting" instead of undergoing immediate treatment and have better quality of life while reducing health care costs, according to a study by researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital. Writing in the June 18 issue of the Annals of Internal Medicine, the authors said their statistical...

2013-05-10 23:02:20

New Green Light XPS laser treatment for prostate problems is now an option at Phelps Memorial Hospital Center. This new treatment is faster and more efficient than earlier options. SLEEPY HOLLOW, New York (PRWEB) May 10, 2013 A new laser treatment for Benign Prostate Hyperplasia (BPH) called Green Light XPS is being performed at Phelps Memorial Hospital Center in Sleepy Hollow, New York. There is little bleeding associated with the treatment, so even men taking blood thinners are...

2013-05-08 16:26:46

Two Johns Hopkins University School of Medicine studies presented at the 2013 AUA Annual Meeting demonstrate Decipher's ability to outperform existing tools for predicting metastasis and disease progression SAN DIEGO, May 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for the American Urological Association demonstrated that Decipher(TM), a transformative genomic...

2013-05-07 00:20:31

Guideline provides detailed direction on treatment options for prostate cancer patients SAN DIEGO, May 7, 2013 /PRNewswire/ -- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence. The 81-page document represents an intensive collaboration among experts in the radiation...

2013-05-06 20:31:13

The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to a team of researchers at Henry Ford Hospital in Detroit. Those conclusions will be presented May 5 at the annual meeting of the American Urological Association in San Diego. The starting point of the study was the rapid increase in the use of surgical robots to assist in radical...

2013-05-06 16:27:26

Results from Large Randomized Trial Support Use of Innovative 180 Watt Laser Therapy as a Viable Treatment Option for More Than 110 Million Men Worldwide with Enlarged Prostate MINNETONKA, Minn., May 6, 2013 /PRNewswire/ -- Data to be presented tomorrow at the American Urological Association (AUA) Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia (BPH) with GreenLight XPS(®) laser therapy with MoXy(®) fiber, instead of transurethral resection of the...

2013-05-03 08:25:34

New app gives urologists the ability to share three-dimensional models of vital organs with patients for more complete, in-depth consultations SAN DIEGO and VANCOUVER, British Columbia, May 3, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced the launch of UroSketch 3D(TM), an application available in Apple's App Store and designed specifically for the iPad. The app, which provides a three-dimensional model of the prostate, bladder and surrounding organs for use by physicians...

2013-04-11 16:25:35

David Samadi, MD, robotic prostate surgeon, talks with Fox 5 News about new FDA scrutiny of the da Vinci robot surgical system NEW YORK, April 11, 2013 /PRNewswire/ -- With more than 4,500 robotic prostate surgeries under his belt, David Samadi, MD may be the last person you'd expect to welcome an FDA investigation of robotic surgery. But late Tuesday he appeared on Fox 5 News saying, "Let the FDA do their investigation and clear the air. This is about our prostate cancer patients."...

2013-04-07 23:02:13

Alonso Krangle LLP Continues to Investigate the Growing Number of Da Vinci Robotic Surgery Lawsuits as the Number of Patients Who Have Sustained Da Vinci Robotic Surgery Complications Grows New York, NY (PRWEB) April 07, 2013 Alonso Krangle LLP, a dedicated law firm focused on fighting for the rights of victims harmed by defective or dangerous medical devices, is continuing to investigate Da Vinci robotic surgery complications lawsuit s as allegations of serious and even deadly Da Vinci...